Home/Filings/4/0001387131-20-004483
4//SEC Filing

SULLIVAN GREGORY M 4

Accession 0001387131-20-004483

CIK 0001430306other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 6:24 PM ET

Size

7.8 KB

Accession

0001387131-20-004483

Insider Transaction Report

Form 4
Period: 2020-05-04
SULLIVAN GREGORY M
Chief Medical Officer
Transactions
  • Award

    Stock Option

    2020-05-04+500,000500,000 total
    Exercise: $0.77From: 2021-05-04Exp: 2030-05-04Common Stock (500,000 underlying)
  • Award

    Stock Option

    2020-05-04+500,000500,000 total
    Exercise: $0.96From: 2021-05-04Exp: 2030-05-04Common Stock (500,000 underlying)
Footnotes (2)
  • [F1]The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0001610106

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 6:24 PM ET
Size
7.8 KB